Chronic nicotine treatment counteracts dopamine D2 receptor upregulation induced by a partial meso-diencephalic hemitransection in the rat

Brain Res. 1994 Aug 29;655(1-2):25-32. doi: 10.1016/0006-8993(94)91593-8.

Abstract

To further elucidate the previously demonstrated protective actions of nicotine on lesioned nigrostriatal dopamine (DA) systems (Janson and Møller, Neuroscience, 57 (1993) 931-941), the present receptor binding experiments were carried out. Rats were partially hemitransected at the meso-diencephalic junction and the effects of chronic continuous (-)nicotine treatment (osmotic pumps s.c., 0.125 mg/kg/h, 14 days) on [3H]N-propylnorapomorphine ([3H]NPA) and [3H]methylcarbamylcholine ([3H]MCC) binding were investigated in striatal coronal sections to study the agonist binding sites of DA D2 receptors and nicotinic cholinoceptors, respectively. In saline-treated but not in nicotine-treated rats, the lesion led to an increased Bmax value of [3H]NPA binding. The Bmax value of [3H]MCC binding was increased by nicotine treatment and decreased by the partial hemitransection. These results indicate that chronic nicotine treatment counteracts the lesion-induced upregulation of the high-affinity agonist binding site of the DA D2 receptor, which may be explained by an increased presence of DA via a protective effect of nicotine on neostriatal DA terminals. This action of nicotine may be of interest in the treatment of neurodegenerative diseases such as Parkinson's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apomorphine / analogs & derivatives
  • Apomorphine / pharmacokinetics
  • Autoradiography
  • Carbachol / analogs & derivatives
  • Carbachol / metabolism
  • Diencephalon / drug effects
  • Diencephalon / physiology*
  • Dopamine Agonists / pharmacokinetics
  • Ligands
  • Male
  • Mesencephalon / drug effects
  • Mesencephalon / physiology*
  • Nicotine / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 / drug effects*
  • Receptors, Nicotinic / drug effects
  • Up-Regulation / drug effects*

Substances

  • Dopamine Agonists
  • Ligands
  • Receptors, Dopamine D2
  • Receptors, Nicotinic
  • N-methylcarbamylcholine
  • N-n-propylnorapomorphine
  • Nicotine
  • Carbachol
  • Apomorphine